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FAILURE OF LIPOID THROMBOPLASTIN TO ACT AS COFACTOR
FOR TRYPSIN IN THE ACTIVATION OF PROENZYMES*
Trypsin is known to activate certain proenzymes, including trypsinogen and
chymotrypsinogen.7 It also activates prothrombin." In the case of pro-
thrombin activation, platelets have been shown to complement the effect of
trypsin. Small quantities of trypsin and platelets together exert a much
greater effect than the sum of their separate effects.9 Lipoid thromboplastin
has been found to complement trypsin in a similar manner."'
The mechanism of this complementary effect is unknown. Therefore, it
is of interest to inquire whether lipoid thromboplastin functions as a simple
cofactor for trypsin in the activation of proenzymes, generally.
MATERIALS AND METHODS
Buffer: 0.9 per cent NaCl; 0.02M veronal buffer, pH 7.4.
Prothrombin preparations: These materials were obtained by modifications of the
methods previously described for prothrombin preparation II10 and prothrombin
preparation III.' Preparation II was obtained by taking the material left in solution
after isoelectric precipitation at pH 4.6 and aging four days at 50 C.; whereas prepara-
tion III was derived from the material precipitated at pH 4.6.
Lipoid thromboplastin (lipid): A cephalin-containing fraction from bovine brain,
prepared as described previously.'
Crystallized trypsin: Supplied by Armour and Co., Chicago. Three hundred mg. of
this material, containing about 120 mg. protein (plus 180 mg. magnesium sulfate) was
dissolved in 20 ml. 0.0025M HCl and dialyzed against cold 0.0025M HCl.
Crystallized chymotrypsinogen: Prepared by Armour and Co. by a process involving
four crystallizations from ammonium sulfate solution followed by two crystallizations
from alcohol. It was reported by the manufacturer to contain less than 0.3 per cent ash.
One hundred twenty-six mg. was dissolved in 10 ml. 0.0025 M HCl to give the stock
solution.
Crystallized trypsinogen: Prepared according to the method of Kunitz and Northrop'
by Worthington Biochemical Laboratory, Freehold, New Jersey.
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Inhibitor-free trypsinogen: Prepared from crystallized trypsinogen in this laboratory
according to the method described by Kunitz'; 570 mg. of moist filter-cake were
dissolved in 5.7 ml. 0.005M HC1 to give the stock solution.
Assay for thrombin: As described.8
Rennet activity of chymotrypsin: As described by Northrop, Kunitz, and Herriott.'
Proteolytic activity: Casein digestion method of Kunitz.'
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FIG. 1. Activation of prothrombin by tryp-
sin without added lipoid thromboplastin, and
with lipoid thromboplastin added at different
times. One-tenth ml. prothrombin was mixed
with 0.7 ml. buffer, 0.1 ml. of a 1:100 dilu-
tion of lipoid thromboplastin, 0.1 ml. of a
1: 1,000 dilution of stock trypsin, and 0.1 ml.
CaC}2 0.0275M. In a parallel experiment,
buffer was substituted for lipoid thrombo-
plastin. A separate pair of experiments was
set up at the same time and in the same way,
except that each contained 0.1 ml. less of
buffer. This pair was allowed to incubate for
30 minutes without removal of samples.
Then, 0.1 ml. lipoid thromboplastin was
added to the mixture which had not received
the lipid at the start; and 0.1 ml. buffer was
added to the one which had started with
added lipid. The activation mixtures con-
tained 0.00055 mg. trypsin per ml. All tests
were performed at room temperature.
EXPERIMENTAL
Figure 1 deals with the activa-
tion of prothrombin by trypsin.
There it is apparent that lipoid
thromboplastin, added either at
the start or during the activation
of prothrombin, increased the
rate of thrombin production.
When the lipid was added at 30
minutes, the curve of thrombin
production did not shift suddenly
to the upper curve, but ap-
proached it gradually. If the lipid
effect had been due to a direct
influence on the estimation of
thrombin, the curve would have
shifted immediately.
These and previous' results
eliminate the possibility that the
lipid effect depends on a spurious
increase in thrombin values. It
must be concluded that the net
production of thrombin is ac-
tually faster in the presence of
the lipid.
When crystallized chymotrypsinogen was used as the proenzyme, the
results were quite different. Even though calcium chloride was included, the
lipid had no effect on the activation of chymotrypsinogen by trypsin, as
shown in Figure 2. The comparatively large amounts of protein materials
used in this experiment were dictated by the standard methods used. If less
chymotrypsinogen had been used, the rennet (milk-clotting) activity would
have been hard to measure in the early stages of activation.
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Consequently, a separate series of experiments was done in which the
activation of chymotrypsinogen was followed by estimating its increasing
proteolytic activity. Four pairs of tests covered the range of 57 to 456
micrograms of chymotrypsinogen per ml. activation mixture. In each case,
the proenzyme was activated by 0.00055 mg. of trypsin per ml. activation
mixture, the same concentration as that used for the prothrombin activation
of Figure 1. Lipoid thrombo-
plastin was added to one test of
each pair. In no case did the lipid
make any significant difference in
the activation of chymotryp-
sinogen.
Certain aspects of trypsinogen
activation seemed to offer a more
favorable chance of detecting an
effect. In the first place, ionic cal-
cium is known to be required for
the effect of lipoid thromboplas-
tinl0; and it is also known to be
favorable for the activation of
trypsinogen.7 Secondly, because it
is autocatalytic, the activation of
trypsinogen is sensitive to a
slight, early acceleration. A co-
factor, even if it remained effec-
tive for only a short time, would
shift the sigmoid portion of the
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FIG. 2. Activation of crystallized chymo-
trypsinogen by crystallized trypsin, with and
without lipoid thromboplastin. One ml. stock
chymotrypsinogen was mixed with 6 ml.
buffer, 1 ml. CaCl2 0.0275M, and 1 ml. of a
1:100 dilution of lipoid thromboplastin. Acti-
vation was begun by adding 2 ml. of a 1: 200
dilution of stock trypsin. In the control, 1 ml.
buffer was substituted for the thromboplastin.
There were 1.1 mg. chymotrypsinogen and
0.0055 mg. trypsin in each ml. activation
mixture. The activations were carried out at
room temperature; but the serial tests for
rennet activity were performed at 350 C.
curve to an earlier position. It would have an effect similar to that of seed-
ing the reaction with a small amount of trypsin. No such effect is evident
in Figure 3.
As these negative findings accumulated, it was necessary repeatedly to
verify the activity of the stock thromboplastin. By chance, one recheck was
negative-the stock lipid now had little or no effect on the activation of
prothrombin by crystallized trypsin. However, further tests soon showed
that it was the prothrombin reagent which had changed, rather than the
lipid. This was originally encountered with prothrombin preparation I,10 a
material obtained by adsorption with magnesium hydroxide.8 When fresh,
this preparation gave a pair of curves like that of prothrombin preparation
III in Figure 4. However, after several days' storage at 50 C. it gave a pair
of curves like that of prothrombin preparation II. This difference in
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reaction-pattern has been encountered many times since, on several occa-
sions with prothrombin preparations tested simultaneously.
During work on purification of prothrombin, this reaction-pattern has
been used as another means of characterizing prothrombin fractions. Vari-
ous preparations have shown varying degrees of difference in their throm-
bin production curves, with and without added lipoid thromboplastin.
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FIG. 3. Autocatalytic activation of crystallized trypsinogen, with and without lipoid
thromboplastin. Stock trypsinogen was diluted 1:2.5 and 1: 25 with 0.005M HCl;
0.5 ml. diluted trypsinogen was mixed with 3.5 ml. buffer, 0.5 ml. of a 1:100 dilution
of lipoid thromboplasti nand 0.5 ml. CaCl2 0.2M. In the controls, buffer was substituted
for thromboplastin. The curves are labelled according to the final dilutions of stock
trypsinogen in the activation mixtures. They correspond respectively to trypsinogen
concentrations of the order of 0.025 and 0.25 mg. per ml. activation mixture. Activa-
tions were carried out at 4-5° C. Serial tests for proteolytic activity were done at 350 C.
DISCUSSION
In the experiments reported, lipoid thromboplastin failed to behave as
simple cofactor for trypsin in the activation of chymotrypsinogen, trypsino-
gen, and prothrombin preparation II. But the lipid seemed to behave as
cofactor for trypsin in the activation of prothrombin preparation III.
Conceivably, the prothrombin molecules in preparation II may have been
different from those in preparation III. Or the difference in behavior may
have depended on the impurities in the prothrombin preparations. In the
latter case, several mechanisms other than simple cofactor action would be
conceivable.9 The possibility that the lipid takes part in a more complex
cofactor effect is not eliminated. And the possibility that the lipid combats
an anticoagulant is still open.
Further investigation of these possibilities would be more profitable as
the purification of clotting factors progresses. Meanwhile, the difference in
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rate of thrombin production, observed with and without lipid, serves as an
additional means of characterizing prothrombin fractions. This applies
specifically to those cases in which crystallized trypsin is used as the
activator and the prothrombin contains little, if any, thrombokinase as a
contaminant.
It is of particular interest to note the trend of the evidence concerning the
function of lipoid thromboplastin. Howell, himself, did not believe that his
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FIG. 4. Activation of two different prothrombin preparations by crystallized trypsin,
with and without added lipoid thromboplastin. One-tenth ml. prothrombin preparation
III was mixed with 0.7 nml, buffer, 0.1 ml. of a 1:100 dilution of lipoid thromboplastin,
0.1 ml. of a 1:1,000 dilution of stock trypsin and 0.1 ml. CaC12 0.0275M. In the control,
buffer was substituted for thromboplastin. On a different day, 0.2 ml. prothrombin
preparation II was mixed with 0.6 ml. buffer, 0.1 ml. lipoid thromboplastin, 1:100,
0.1 ml. trypsin, 1:1,000 and 0.1 ml. GaCls 0.0275M. The control had buffer instead of
thromboplastin. All tests were performed at room temperature.
"cephalin" was a direct activator of prothrombin.8 It has long been known1
that partially purified prothrombin is activated only very slowly in the
presence of calcium and "cephalin." A negative result after an incubation
period of 80 minutes has been reported.9 More recently, it has been possible
in this laboratory to obtain a prothrombin preparation which was less than
one per cent activated after 28 hours with calcium and lipoid thrombo-
plastin at room temperature.12 Now an example has been presented (Fig. 4)
in which the lipid had very little effect, even as an accessory factor for the
production of thrombin.
SUMMARY
In the experiments reported, lipoid thromboplastin failed to function as
simple cofactor for trypsin in the activation of crystallized chymotrypsino-
gen, crystallized trypsinogen, and certain preparations of prothrombin.
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With other preparations of prothrombin, the lipid seemed to act as cofactor
for trypsin; but this may well have been due to some effect other than
simple cofactor action. Since different prothrombin preparations behaved
differently in the test system, this system has been used as an additional
means of characterizing prothrombin fractions.
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